BioHealth News Archive
Novavax tailoring Covid-19 vaccine to Omicron variant while advancing campus expansion plans – Washington Business Journal
The company said Thursday it’s implementing “a two-pronged variant strategy” for the variant. {iframe}https://www.bizjournals.com/washington/news/2021/12/02/novavax-covid-vaccine-omicron-variant-expansion.html{/iframe}
Read More
Possible Life Sciences and Biotechnology Office Building Coming to Pike & Rose in Location Currently Occupied by Bark Social – The MoCo Show
Possible Life Sciences and Biotechnology Office Building Coming to Pike & Rose in Location Currently Occupied by Bark Social We recently learned of plans…
Read More
United Therapeutics Named by Newsweek as One of America’s Most Responsible Companies 2022 | BioSpace
SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)-- United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation with a purpose to provide a…
Read More
PharmaShots Interview: Cartesian Therapeutics’s Dr. Murat Kalayoglu Shares Insight on RNA Cell Therapy for an Autoimmune Disease
In an interview with PharmaShots, Dr. Murat Kalayoglu, MD, Ph.D., President, and Chief Executive Officer at Cartesian Therapeutics shared his insights on the P-I/IIa study…
Read More
Baltimore Startup Rasio Therapeutics Raises $1.5M for Software to Develop Drugs
A Baltimore startup that uses computer software to develop cancer drugs has raised $1.5 million in new funding, according to a recent filing. …
Read More
AB Agri has Partnered with Maryland’s Intralytix, Inc. to Explore the Use of Bacteriophages
Peterborough, 30 November 2021 Gut health could be boosted without reliance on antibiotics and other medicines Bacteriophages are natural and abundant Exploration aligns with…
Read More
Maryland’s Novavax working on its version of COVID-19 vaccine to target omicron variant
GAITHERSBURG, Md. (7News) — The Omicron variant is quickly becoming a household name but the hope is that it won’t enter households here in the D.C. area.…
Read More
Healthtech companies reap benefits of robust year in venture capital funding | Healthcare Finance News
Venture capital investment in global healthtech companies is projected to reach $42 billion by the end of the year, according to Silicon Valley Bank's…
Read More
Bank of antibodies against nasty viruses that’s proposed for Maryland aims to prevent next pandemic.
As the world continues to grapple with the coronavirus pandemic that has claimed more than 5 million lives, a group of researchers is working…
Read More
BioHealth Capital Region Spotlight: Creative Bio-Peptides Awarded $5.78 Million from NIH to Develop Breakthrough Treatments for Neuroinflammatory/Neurodegenerative Indications
Creative Bio-Peptides, Inc., an emerging drug development company focused on the development of leading-edge multi-chemokine antagonist therapeutic peptides for neuroinflammatory/neurodegenerative conditions, has been awarded…
Read More
Alexandria Venture Investments, One of the Year’s Top Five Most Active U.S. Investors in Agrifoodtech, Accelerates Its Mission-Critical Investment Activity in a Sector Experiencing Tremendous Upsurge in Venture Funding
PASADENA, Calif., Nov. 29, 2021 /PRNewswire/ -- Alexandria Venture Investments, the strategic venture capital platform of Alexandria Real Estate Equities, Inc. (NYSE: ARE), an…
Read More
Emmes Announces Completion of Third ACTT Clinical Trial for COVID-19
ROCKVILLE, Md., Nov. 29, 2021 /PRNewswire/ -- Emmes today announced that it conducted the data and statistical analysis for the third iteration of the…
Read More
Montgomery County Hires State House Vet to Coordinate White Flint BioHub Proposal
Montgomery County failed in its bid lure Amazon, the e-commerce giant that opted to build its second headquarters in Arlington, Va. But top county…
Read More
Supernus Pharmaceuticals Completes Acquisition of Adamas Pharmaceuticals
Acquisition strengthens Parkinson’s disease portfolio and diversifies revenue and cash flow ROCKVILLE, Md., Nov. 24, 2021 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN)…
Read More
QIAGEN reaffirms effectiveness of its SARS-CoV-2 PCR tests in light of the new coronavirus variant B.1.1.529
November 26, 2021 HILDEN, Germany & GERMANTOWN, Maryland--(BUSINESS WIRE)-- QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced its polymerase chain reaction (PCR) tests…
Read More